Cargando…
Editorial: Novel Strategies for Anti-Tumor Vaccines
Autores principales: | Accolla, Roberto S., Buonaguro, Luigi, Melief, Cornelis, Rammensee, Hans-George, Bassani-Sternberg, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979277/ https://www.ncbi.nlm.nih.gov/pubmed/32010150 http://dx.doi.org/10.3389/fimmu.2019.03117 |
Ejemplares similares
-
Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
por: Lill, Jennie R., et al.
Publicado: (2022) -
CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
por: Accolla, Roberto S., et al.
Publicado: (2019) -
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
por: Celesti, Fabrizio, et al.
Publicado: (2023) -
Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
por: Gfeller, David, et al.
Publicado: (2018) -
Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022)